加载中...
2025-03-25The 22nd China International In Vitro Diagnostic Expo (CACLP) was grandly opened at the Hangzhou Grand Convention and Exhibition Center from March 22 to 24. As a benchmark event in the field of in vitro diagnostics (IVD) in the world, this expo attracted internationally renowned companies and industry elites to participate in the event. Lifotronic, with the "Intelligent Emergency Testing Solution" as the core, made a high-profile appearance with a variety of innovative product matrices, and quickly became the focus of technology attention.
As the digital transformation of medical care accelerates, the field of emergency testing is undergoing a profound transformation in automation, intelligence and precision. Lifotronic, relying on cutting-edge technology layout, closely focuses on improving emergency medical rescue capabilities and emergency treatment capabilities, launched the "Intelligent Emergency Testing Solution" at the exhibition, demonstrating its strong strength in leading the industry's technological innovation.
The fully automatic electrochemiluminescence system LifoLas 8000 is an intelligent tailor-made product for emergency testing. Through the seamless direct connection between the fully automatic sample processing system and up to 4 modules eCL9000 ECLIA analyzer, the platform achieves detection speed up to 1200T/H. Its "9-minute rapid detection mode" covers essential emergency indicators, including cardiac, inflammation, and acute abdomen markers. This significantly optimizes the turnaround time (TAT) for emergency detection, providing vital diagnostic support during the golden treatment window for critically ill patients, such as those with chest pain, stroke, and septic shock.
The H100Plus integration system combines precision, efficiency, and intelligence. It adopts the gold standard methodology for HbA1c detection—ion exchange high-performance liquid chromatography (HPLC)—and is capable of detecting multiple variants simultaneously. With intelligent reagent management and fully automatic sample processing, this system achieves a breakthrough in detection efficiency and operational experience, thereby supporting accurate screening, diagnosis, and monitoring of diabetes.
As a practitioner of intelligent medical products, Lifotronic is accelerating the development of an integrated innovation system for intelligent medical care. In the future, Lifotronic will continue to leverage technological innovation as a driving force to advance medical diagnosis towards greater efficiency, precision, and inclusiveness, contributing to the development of a new generation of intelligent medical ecology!
